|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Fedewa SA, Goding Sauer A,
Kramer JL, Smith RA and Jemal A: Breast cancer statistics, 2015:
Convergence of incidence rates between black and white women. CA
Cancer J Clin. 66:31–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marcuzzi E, Angioni R, Molon B and Calì B:
Chemokines and chemokine receptors: Orchestrating tumor
metastasization. Int J Mol Sci. 20:E962018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Franciszkiewicz K, Boissonnas A, Boutet M,
Combadière C and Mami-Chouaib F: Role of chemokines and chemokine
receptors in shaping the effector phase of the antitumor immune
response. Cancer Res. 72:6325–6332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Svensson M and Agace WW: Role of
CCL25/CCR9 in immune homeostasis and disease. Expert Rev Clin
Immunol. 2:759–773. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heinrich EL, Arrington AK, Ko ME, Luu C,
Lee W, Lu J and Kim J: Paracrine activation of chemokine receptor
CCR9 enhances the invasiveness of pancreatic cancer cells. Cancer
Microenviron. 6:241–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li MQ, Wang Y, Chang KK, Meng YH, Liu LB,
Mei J, Wang Y, Wang XQ, Jin LP and Li DJ: CD4+Foxp3+ regulatory T
cell differentiation mediated by endometrial stromal cell-derived
TECK promotes the growth and invasion of endometriotic lesions.
Cell Death Dis. 5:e14362014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vicari AP, Figueroa DJ, Hedrick JA, Foster
JS, Singh KP, Menon S, Copeland NG, Gilbert DJ, Jenkins NA, Bacon
KB and Zlotnik A: TECK: A novel CC chemokine specifically expressed
by thymic dendritic cells and potentially involved in T cell
development. Immunity. 7:291–301. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thomas JK, Mir H, Kapur N, Bae S and Singh
S: CC chemokines are differentially expressed in breast cancer and
are associated with disparity in overall survival. Sci Rep.
9:40142019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang C, Liu Z, Xu Z, Wu X, Zhang D, Zhang
Z and Wei J: The role of chemokine receptor 9/chemokine ligand 25
signaling: From immune cells to cancer cells. Oncol Lett.
16:2071–2077. 2018.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Liu R, Zhu W, Chu H, Yu H, Wei P,
Wu X, Zhu H, Gao H, Liang J, et al: UDP-glucose accelerates SNAI1
mRNA decay and impairs lung cancer metastasis. Nature. 571:127–131.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Greenburg G and Hay ED: Epithelia
suspended in collagen gels can lose polarity and express
characteristics of migrating mesenchymal cells. J Cell Biol.
95:333–339. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tomaskovic-Crook E, Thompson EW and Thiery
JP: Epithelial to mesenchymal transition and breast cancer. Breast
Cancer Res. 11:2132009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mallini P, Lennard T, Kirby J and Meeson
A: Epithelial-to-mesenchymal transition: What is the impact on
breast cancer stem cells and drug resistance. Cancer Treat Rev.
40:341–348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Santamaria PG, Moreno-Bueno G, Portillo F
and Cano A: EMT: Present and future in clinical oncology. Mol
Oncol. 11:718–738. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou C, Wu J, Borillo J, Torres L, McMahon
J and Lou YH: Potential roles of a special CD8 alpha alpha + cell
population and CC chemokine thymus-expressed chemokine in ovulation
related inflammation. J Immunol. 182:596–603. 2019. View Article : Google Scholar
|
|
20
|
Meurens F, Whale J, Brownlie R, Dybvig T,
Thompson DR and Gerdts V: Expression of mucosal chemokines
TECK/CCL25 and MEC/CCL28 during fetal development of the ovine
mucosal immune system. Immunology. 120:544–555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zabel BA, Agace WW, Campbell JJ, Heath HM,
Parent D, Roberts AI, Ebert EC, Kassam N, Qin S, Zovko M, et al:
Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is
selectively expressed on intestinal homing T lymphocytes, mucosal
lymphocytes, and thymocytes and is required for thymus-expressed
chemokine-mediated chemotaxis. J Exp Med. 190:1241–1256. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kunkel EJ, Campbell JJ, Haraldsen G, Pan
J, Boisvert J, Roberts AI, Ebert EC, Vierra MA, Goodman SB,
Genovese MC, et al: Lymphocyte CC chemokine receptor 9 and
epithelial thymus-expressed chemokine (TECK) expression distinguish
the small intestinal immune compartment: Epithelial expression of
tissue-specific chemokines as an organizing principle in regional
immunity. J Exp Med. 192:761–768. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gupta P, Sharma PK, Mir H, Singh R, Singh
N, Kloecker GH, Lillard JW Jr and Singh S: CCR9/TECK expression in
non-small cell lung cancer correlates with aggressive disease and
mediates key steps of metastasis. Oncotarget. 30:10170–10179.
2014.
|
|
24
|
Tu Z, Xiao R, Xiong J, Tembo KM, Deng X,
Xiong M, Liu P, Wang M and Zhang Q: CCR9 in cancer: Oncogenic role
and therapeutic targeting. J Hematol Oncol. 16:102016. View Article : Google Scholar
|
|
25
|
Cifuentes N and Pickren JW: Metastases
from carcinoma of mammary gland: An autopsy study. J Surg Oncol.
11:193–205. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rezaeeyan H, Shirzad R, McKee TD and Saki
N: Role of chemokines in metastatic niche: New insights along with
a diagnostic and prognostic approach. APMIS. 126:359–370. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ben-Baruch A: Organ selectivity in
metastasis: Regulation by chemokines and their receptors. Clin Exp
Metas. 25:345–356. 2008. View Article : Google Scholar
|
